trial

Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis

NCTId NCT01119014
as of 2026-07-01
at a glance
Phase 4 · Completed
Enrollment 300 (actual)
Sponsored by Anne Katrine Pagsberg
Primary completion 2015-07
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Completed
Enrollment
300 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2010-05
Primary completion
2015-07
Eligibility
ALL · 12 Years · 17 Years

Interventions & indications

Sponsors

Investigators

9
Anne Katrine Pagsberg, MD, Ph.D.Principal Investigator
Pia Jeppesen, MD, Ph.D.Principal Investigator
Maj-Britt Lauritsen, MDPrincipal Investigator
Marlene Briciet Lauritsen, MD.Principal Investigator
Niels Bilenberg, Professor, MD.Principal Investigator
Thomas Werge, Professor, Ph.D.Principal Investigator
Jesper Pedersen, MD.Principal Investigator

Sites

9 total
Aalborg, DenmarkCopenhagen, DenmarkCopenhagen, DenmarkGlostrup Municipality, DenmarkHillerød, DenmarkOdense, DenmarkRisskov, DenmarkRoskilde, DenmarkRoskilde, Denmark

Facts & assertions

4 sourced
Enrollment
300
Phase
PHASE4
Primary Completion Date
2015-07
Status
COMPLETED